NewAmsterdam Pharma NAMS
NASDAQ NAMS
$19.18 +0.20 (+1.05%)
At close: Nov 10, 2026 · 4:00 PM EST

NewAmsterdam Pharma (NAMS) Other Non-Current Liabilities (2022 - 2026)

Updated

Analysis

NewAmsterdam Pharma (NAMS) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 NewAmsterdam Pharma 2.30 Bn -236.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 31.33 Mn
Jun 30, 2026 54.45 Mn
Mar 31, 2026 50.23 Mn
Dec 31, 2025 57.27 Mn
Sep 30, 2025 44.36 Mn
Jun 30, 2025 20.93 Mn
Mar 31, 2025 23.52 Mn
Dec 31, 2024 44.80 Mn
Sep 30, 2024 18.81 Mn
Jun 30, 2024 13.39 Mn
Mar 31, 2024 16.49 Mn
Dec 31, 2023 7.79 Mn
Jun 30, 2023 8.21 Mn
Dec 31, 2022 7.52 Mn
API Access

NewAmsterdam Pharma Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NAMS&period=max&api_key=YOUR_API_KEY